Post by California Institute for Regenerative Medicine (CIRM)

The USC Roski Eye Institute and Keck Medicine of USC are launching a CIRM-funded Phase 2b clinical trial to test a stem cell-derived retinal implant for advanced dry age-related macular degeneration, a leading cause of vision loss in older adults. The study will examine whether the implant can safely replace damaged retinal cells and improve vision for patients with few treatment options. Learn more: https://bit.ly/4p59fPE